If this email is not displayed correctly please click here

Arbitration & ADR

24 September 2020
Martin J Valasek Arbitrating disputes in pharmaceutical, life sciences and healthcare sector during COVID-19 pandemic

International - Norton Rose Fulbright

COVID-19 is putting tremendous strain on the life sciences and healthcare sector. Disputes may be more disruptive than usual during this time, not least because they put further pressure on often already limited financial and managerial resources. Therefore, many parties are seeking alternative ways to avoid disputes. However, some disputes are inevitable and a number are likely to be resolved through international arbitration.

Authors: Martin J Valasek, Brian R Daley, Jordana Sanft, Randy C Sutton
Read more

Recent updates

Philip Roche COVID-19: preliminary arbitration trends in transport sector

International - Norton Rose Fulbright

Authors: Philip Roche, Vanessa Rochester
Raúl Herrera Hazas Tribunal dismisses all of investor's claims under NAFTA and orders him to pay more than $2 million in costs

Mexico - Becerril Coca & Becerril SC

Author: Raúl Herrera Hazas
Frank Spoorenberg Supreme Court will not review findings that parties lacked actual and common intent to arbitrate

Switzerland - Tavernier Tschanz

Authors: Frank Spoorenberg, Daniela Franchini
Atul Shanker Mathur Enforcement of foreign arbitral awards and scope of judicial intervention: a minimalist approach

India - Khaitan & Co

Authors: Atul Shanker Mathur, Priya Singh, Vivek Mathur